CompletedNCT06477276
Amygdala stimulation research study for depression
About this title
Read the official source — NCT06477276Device studyAges 18–65China
Understand this study
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- Shanghai and 2 more locationsSee all locations and recruitment
Study information
Study start dateStarted: July 24, 2024
- Recruitment status
- Completed
- Enrollment listed in the registry
- 92
- Sponsor
- Ruijin Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Device
- Intervention type
- DEVICE
- Study phase
- Not clearly listed
- Locations
- China
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06477276
- Official title
Show the full official title
A Multicenter, Randomized, Controlled, Double-Blind Trial on the Efficacy and Safety of Amygdala Temporal Interference Stimulation for the Treatment of Depression.
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedShanghai · Tianjin
Questions about this study
Who is behind this study?
The study sponsor is Ruijin Hospital, a hospital or academic medical center.
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
